Skip to content

Comparison of the effect of passiflora plant and mefenamic acid on primary dysmenorrhoea

Comparison of the effect of Passiflora (Relax Herb) capsule and mefenamic acid capsule on primarydysmenorrhea

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230406057831N1
Enrollment
165
Registered
2023-06-13
Start date
2023-05-21
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea.

Interventions

Intervention 1: Intervention group:. Intervention 2: Control group:.

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: single age 18-25 years old regular menstrual cycle (25-30 days) occurrence of pain before or at the same time as menstrual bleeding moderate to severe pain intensity (4 to 10 points) based on visual analogue pain index in three days at First, menstrual bleeding no history of abdominal and pelvic surgery no symptoms such as burning, itching or abnormal secretions no stressful factors such as the death of 1st degree relatives separation of parents, etc. in the last 6 months no smoking no drug allergy

Exclusion criteria

Exclusion criteria: body mass index above 30 sensitivity to non-steroidal anti-inflammatory drugs such as mefenamic acid use of oral contraceptives, supplements or any drug and herbal decoction suffering from medical diseases such as organ disease. Genital, heart, lung disease, endocrine disorders, metabolic disease, gastric or duodenal ulcer, digestive, liver and kidney disease use of drugs that suppress the central nervous system, anticoagulants and antihypertensive drugs suffering from mental illnesses. According to the patient, it is like depression, severe anxiety and severe stress

Design outcomes

Primary

MeasureTime frame
Severity of primary dysmenorrhoea. Timepoint: Measurement of primary dysmenorrhea before the start of the study and in the first three days of menstruation for two months. Method of measurement: Visual analog scale of pain.;Duration of primary dysmenorrhea. Timepoint: Measuring the duration of primary dysmenorrhea before the start of the study and in the first three days of menstruation for two months. Method of measurement: The duration of primary dysmenorrhea is measured in minutes.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Simin Montazeri

Ahvaz University of Medical Sciences

montazeri-s@ajums.ac.ir+98 61 3311 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026